Introduction
Daurismo is a targeted cancer therapy that was developed to provide an additional treatment option for adults with newly diagnosed AML who are not candidates for intensive induction chemotherapy. Used in combination with low-dose cytarabine, Daurismo targets a specific signaling pathway involved in leukemia cell growth and survival.
Because Daurismo is a specialty oncology medication, treatment expenses can be significant. Many patients and caregivers researching the Daurismo patient assistance program need ways to reduce out-of-pocket medication costs while maintaining access to prescribed treatment.
Prescription Hope is a medication access service that advocates on patients’ behalf to patient assistance programs throughout the application process, and after a qualified patient receives approval.
What Is the Daurismo Patient Assistance Program?
Understanding Daurismo Prescription Assistance
Some brand-name medications are too expensive for the average American to afford without assistance or adequate insurance coverage.
Pharmaceutical manufacturers understand this and have developed patient assistance programs to help qualified patients access their brand-name medications at affordable rates.
However, patient assistance programs are often complex and difficult to navigate. Patients report feeling frustrated and overwhelmed when taking on the application process alone.
Thankfully, there is a solution.
How Expert Advocates Help Make Daurismo More Affordable
Professional Application Management
Prescription Hope is a patient support service for those who need access to affordable medications through patient assistance programs. We take care of the application process from start to finish, including completing forms, collecting documents and signatures, and coordinating with manufacturers.
Ongoing Patient Support
Not only do we help you with your Daurismo assistance application, but our patient-centered support services mean peace of mind for as long as you are a patient with Prescription Hope. We handle administrative requirements such as refill scheduling, document updates, yearly renewals, program monitoring, and more.
Daurismo Price Comparison
vs
Estimated Retail Price*
30-Day Supply
Prescription Hope Price
Per Month, NO Matter The Retail Price
*Source: Drugs.com
Predictable Monthly Pricing
All services included in Prescription Hope’s prescription access solutions are covered with a simple $70.00 per month, per medication. That means no surprise fees or charges and no medication costs.
Those who don’t qualify for their intended patient assistance program may still benefit from Prescription Hope’s services. Our team can help you find alternative ways to save, such as discount cards, coupons, substitute medications and their programs, and more.
And if we can’t help you save, you pay nothing.
Daurismo Patient Assistance Eligibility
General Eligibility Requirements
Wondering who qualifies for Daurismo assistance? Curious about prescription assistance requirements?
All patient assistance programs hold strict requirements for qualification, though each program’s standards are different. However, most requirements fall into several general categories:
Income: Each program holds its own income threshold requirements.
Insurance: Every program maintains unique insurance coverage status criteria.
Prescription: All programs require a valid prescription for the medication you wish to qualify for.
Residency: All programs require legal US residency to qualify.
Simple Enrollment With Expert Support
Getting Started With Enrollment
Registration support for the Daurismo Patient Assistance Program can be enrolled through Prescription Hope. Enrollment takes 6 simple steps:
- Submit Information: Patients can complete our online enrollment form in a few minutes.
- Advocate Contact: A patient advocate will reach out within 1-2 business days.
- Document Collection: After prequalification, our team will collect all necessary documents.
- Provider Coordination: Our team will also gather all needed signatures from your healthcare providers.
- Program Submission: Once everything is in order, we submit your application and coordinate with the manufacturer throughout the application processing stage.
- Medication Delivery: After approval, patients often receive their medication within 2 weeks. All medications ship directly from the manufacturer to your door or doctor’s office.
Continued Treatment Access
Prescription Hope’s long-term treatment access can offer the oncology medication support patients need when taking Daurismo.
Our team of patient advocates works hard to handle all tasks required to access all patient assistance programs. We manage refill scheduling, document updates, yearly renewals, program monitoring, and more.
Understanding Daurismo
How Daurismo Works
Daurismo contains the active ingredient glasdegib, a targeted cancer therapy known as a Hedgehog pathway inhibitor. More specifically, it works by blocking a protein called Smoothened (SMO), which plays an important role in the Hedgehog signaling pathway.
The Hedgehog pathway can contribute to the growth, survival, and maintenance of certain leukemia cells, including leukemia stem cells. By inhibiting this pathway, Daurismo may help slow the growth of leukemia cells and interfere with their ability to survive and multiply.
Daurismo is used in combination with low-dose cytarabine, a chemotherapy medication. Together, these treatments attack acute myeloid leukemia through different mechanisms, providing a lower-intensity treatment option for eligible patients who are not candidates for intensive chemotherapy.
What Conditions Does Daurismo Treat?
Daurismo is FDA-approved for use in combination with low-dose cytarabine for the treatment of newly diagnosed acute myeloid leukemia in adults who are either 75 years of age or older, or who have medical conditions that make intensive induction chemotherapy inappropriate.
Acute myeloid leukemia is a cancer of the blood and bone marrow characterized by the rapid growth of abnormal white blood cells. These abnormal cells can interfere with the body’s ability to produce healthy blood cells and may lead to symptoms such as fatigue, infections, bleeding, and shortness of breath.
Healthcare providers may prescribe Daurismo when a lower-intensity treatment approach is needed because of a patient’s age, overall health status, or other medical considerations that limit the use of more aggressive chemotherapy regimens.
Benefits of Treatment
Daurismo offers an important treatment option for adults with newly diagnosed AML who may not be suitable candidates for intensive induction chemotherapy. By targeting the Hedgehog signaling pathway, the medication works differently from traditional chemotherapy and may help improve treatment outcomes when used alongside low-dose cytarabine.
Potential benefits include helping control leukemia cell growth, targeting leukemia stem cells, supporting treatment responses, and providing an oral therapy option that can be taken at home under oncology supervision.
For eligible patients, Daurismo may provide a meaningful treatment option that balances effectiveness with a lower-intensity treatment approach. Treatment outcomes vary among individuals, and healthcare providers monitor response through laboratory testing, clinical evaluations, and ongoing assessment throughout therapy.
Important Safety Information and Side Effects
Daurismo carries an FDA Boxed Warning for Embryo-Fetal Toxicity. The medication can cause fetal harm, severe birth defects, or embryo-fetal death if exposure occurs during pregnancy. Pregnancy testing should be performed before treatment in females who can become pregnant, and effective contraception is required during treatment and for a specified period after therapy ends.
Common side effects reported with Daurismo in combination with low-dose cytarabine include anemia, fatigue, fever, nausea, decreased appetite, constipation, bleeding or bruising, low platelet counts, muscle pain, swelling of the arms or legs, shortness of breath, and changes in taste.
Daurismo may cause QT interval prolongation, a potentially serious heart rhythm abnormality that can increase the risk of life-threatening arrhythmias. Healthcare providers may perform electrocardiograms (ECGs) and monitor electrolyte levels before and during treatment to help reduce this risk.
The medication may also contribute to blood cell abnormalities, including anemia, thrombocytopenia, and neutropenia. Because AML treatment can significantly affect blood cell production, routine blood monitoring is required throughout therapy.
Patients should promptly report symptoms of infection, such as fever, chills, persistent cough, or other signs of illness. AML and its treatments can increase susceptibility to serious infections.
Muscle-related side effects, including muscle pain, weakness, tenderness, and elevated creatine kinase levels, have also been reported. Healthcare providers may monitor creatine kinase levels, particularly if muscle symptoms develop.
Breastfeeding is not recommended during treatment and for at least 30 days after the final dose because of the potential for serious adverse reactions in a nursing infant. Male patients should not donate semen during treatment and for at least 30 days after the final dose.
Important drug interactions may occur with medications that prolong the QT interval, certain antifungal medications, some antibiotics, and strong CYP3A4 inhibitors or inducers. Patients should provide a complete list of medications, vitamins, and supplements before beginning treatment.
Access to Multiple Medications
Support Beyond Daurismo
Getting access to leukemia treatment assistance is the priority for many who need oncology medication. However, many patients also require other medications alongside their other prescriptions.
Prescription Hope specializes in multiple medication assistance programs. For every medication you qualify for, our service rate stays a consistent and simple $70.00 per month, per medication.
Why Choose Prescription Hope for Daurismo Assistance
Experienced Advocacy Support
Our specialized staff supports you throughout your patient assistance program journey, offering expert advocacy so you can rest easy, knowing that all your application bases are covered.
Ongoing Medication Management
Once approved, Prescription Hope patients enjoy knowing that all of the administrative tasks associated with their patient assistance program enrollment are handled. That means things like refill schedules, document updates, yearly renewals, program monitoring, and more are all covered.
Transparent Monthly Pricing
Prescription Hope’s full list of services is all covered under our consistent $70.00 per month, per medication.
If you don’t qualify for your intended program, we’ll help you search for other savings options. We’ve helped patients access things like discount cards, coupons, substitute medications and their programs, and more.
Nationwide Medication Access Support
For 20 years, we’ve cultivated a network that has included hundreds of pharmaceutical manufacturers, tens of thousands of healthcare providers, and industry professionals across the nation.
If you need access to the Daurismo patient assistance program, then be sure to enroll with Prescription Hope today.
